Target acute leukaemia cells in hypoxic bone marrow by suppressing mitochondrial metabolic remodelling
Understanding the complexity of miRNA-regulated pathways in medulloblastoma
Pilot project to investigate the impact of adipokines on Leukaemia (ALL) outcomes
Investigating the potential role of CHD1L, a chromatin-remodelling factor involved in the DNA damage response, in childhood neuroblastoma
Synthesis and evaluation of novel analogues of emetine as a new treatment for leukaemia
PhD Final Year Pump Priming Grant
Transcriptional inhibition of CDK6 resulting in apoptosis and cell cycle blockage in Osteosarcoma (SAOS-2) cell lines
Cyclin-dependent-Kinase inhibitors in medulloblastoma
Development of small-molecule glycomimetics as inhibitors of HGF-Met activation
Natural products Scottish plants
Investigating n-3 PUFAs for potential adjuvant therapy in acute lymphoblastic leukaemia
NEIL3 as a new target for cancer therapy
0161 295 3864 